Pathways to Value: Biopharma's Options for Global Expansion
October 20, 2020 | 1pm ET / 10am PT | Blue Matter Consulting

US biopharma companies have options for ex-US expansion. But how can a company decide on its best pathway to value? In this webinar, leaders who’ve done it outline how they weighed their options and made the right decisions.

USP Elastomer Chapter Revisions Will Become Official December 2020: What you Need to Know
September 17, 2020 11 a.m. EST / 8 a.m. PST | West Pharmaceutical Services, Inc.

This webinar will explain the baseline requirements for elastomeric physicochemical and functional properties.  Examples to illustrate qualification of components for intended applications will be included.  Register now.

Wearable Technology for High-Frequency Cognitive and Mood Assessments in Depression
September 17, 2020 | 11am ET / 8am PT | Cambridge Cognition

The widespread adoption of smartphones and wearables makes monitoring symptoms in real time a credible option using brief measures designed for these devices – but is this acceptable and feasible for patients? This webinar will delve into the research findings of Takeda Pharmaceuticals, Cambridge Cognition, and CTRL Group, and share lessons learned adopting new technologies in clinical trials. Register now.

Overcoming Scalability Challenges with Autologous Therapies
September 15, 2020 | 12pm ET / 9am PT | Catalent

Join experts Prof. Gerhard Bauer and Catalent’s Dr. James Crutchley as they discuss challenges and an innovative methodology to commercially scale autologous therapies. Register now.

Leveraging Innovative Technologies, Best Practices and Strategies to Accelerate Biologics Development and Commercialization
September 9, 2020 | 12pm ET / 9am PT | Thermo Fisher Scientific

This webinar will detail practical implementation of innovative technologies and solutions such as multi-attribute method, modernized cell line development workflow using high-yield cell lines and automated systems, next generation purification resins. It will also showcase best practices and strategies such as phase appropriate quality systems, and integrated drug substance – drug product solutions that leverage standardized technology platforms. Register now!

More Powerful Analytics Capabilities
Acorn AI by Medidata, a Dassault Systèmes company

Acorn AI is a Medidata company that represents the next horizon of the industry leader’s 20-year mission of powering smarter treatments and healthier people. Acorn AI is designed to make data liquid across the entire lifecycle and to answer the most important questions in R&D and commercialization for customers.  Download the case study.

Navigating the Insulin Affordability Act

Extended care programs are available to help people in need. However, as the law rolls out, there are some clear communication disconnections that may make the process cumbersome. Download the eBook to read about a solution designed to connect manufacturers, pharmacists, and patients. In this special guide, you will learn not just about the law but about the portal platform designed to change the entire process for all.

Paid Marketplace
Bioscience Certificate Pathways Advancing Knowledge, Skills, & Careers

Taught by experienced professionals, Biotility’s online short courses provide the knowledge and practical skills valued by the bioscience industry. Enhance your career through coursework in one of our certificate pathways, including Document Management, Operations Management, and Quality Management. Learn more.

Reducing barriers to patient care: A cross-industry collaboration
Thursday, August 27, 2020 | 1pm ET / 10am PT | Optum

Optum brings together cross-industry experts to share a case study detailing how an employer, provider, payer and pharmaceutical company worked together to address a hard-to-diagnose condition: migraine. Register now.

CROs: The Tip of the Spear in Maximizing the Value of Hybrid, Virtual, and Synthetic Clinical Trials
August 26, 2020 | 1pm EST / 10am PST | Rho

Hybrid, Virtual, and Synthetic trials are becoming part of a growing number of drug and biologics development programs. Join us as Rho experts discuss how to maximize the benefits of decentralized trials. Register now!

From Respond to Reboot to Recover: Workforce health and safety are at the heart of resilient recovery
August 26, 2020 | 11 a.m. EST / 8 a.m. PST | Deloitte

Before businesses can recover, they will need to reboot, which will involve developing a holistic approach to managing new health risks, rethinking workforce safety, maximizing productivity, and furthering sales –while protecting and maintaining compliance with privacy and cybersecurity rights. Register now.

Navigating CMC Regulatory Requirements for Accelerated Commercialization
August 25, 2020 | 11 a.m. EST / 8 a.m. PST | Lonza

Join us to discuss strategy, timing, process, practical and execution aspects to be considered in order to achieve a target  outcome. Case studies will be presented that demonstrate each of these challenges and the considerations necessary to meet fast-track timing requirements of clinical trials and registration applications. Register now.

Powering Virtual Trials – In The Cloud
August 19, 2020 11 a.m. EST / 8 a.m. PST | Amazon Web Services

In this webinar you will hear from technology company uMotif on how they collaborate with pharma companies undertaking virtual and decentralized trials. Hear how new patient populations can be reached using cloud-based technology and learn what types of research data can be collected from different devices and wearables. Register now.

Enabling high drug-loaded amorphous dispersion tablets
August 18, 2020 11 a.m. EST / 8 a.m. PST | Lonza Pharma & Biotech

Join us to gain an understanding of how to combine two different polymers, one “inside” and one “outside” the ASD to maximize performance, physical stability, and drug loading of ASD drug products. Register now.

Uncertainties With the Regulatory Environment for Continuous Manufacturing
August 12, 2020 | 11am ET / 8am PT | Thermo Fisher Scientific

Continuous manufacturing brings uncertainties with regulatory and adoption rates. Industry expert, Ajaz S. Hussain, PhD, will discuss these uncertainties and provide more insight into this innovation. Register now!

Reducing the Complexity and Costs of Channel Planning and Logistics
Cardinal Health 3PL Services

How can you make the process of bringing your product to market less complex while also reducing costs?  This eBook identifies opportunities to simplify channel strategies for biopharma companies, their customers and patients. Discover how you can deliver savings and innovation to your business. Download now.

Executive Summary
Keys to a Successful Rapid Commercial Launch

Pharmaceutical and biotech companies are spending years and millions of dollars developing drugs or promising new biologics, all with the hopes of saving or enhancing patients’ lives. It’s a “race to the finish” in some cases, and the quicker a company can get its product to patients, the better. Download now.

Paid Marketplace
Want to Change the World? Join the Phlow Corp. Team
Phlow Corp.

We are seeking talented pharmaceutical executives to join our mission to reliably supply affordable, high-quality, essential medicines through U.S. based advanced manufacturing processes. If you are a driven team player who wants to do something significant and serve patients, we invite you to apply.

How to find today's TOP emerging market trends via medical claims data
LexisNexis Risk Solutions Health Care – Life Sciences

Traditionally, pharma companies use a combination of prescription data & internal sales reports to look for potential buyers. Such practice provides only a LIMITED VIEW without competitor information. Download this whitepaper on best practices to use the RIGHT data for market development strategy.

[eBook] Expecting the Unexpected: Strategies for Efficient Clinical Supply Management and Forecasting

Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Click here to download the eBook.

High-Loaded Dosage Forms: Novel Platform Expands Spray-Dried Dispersion Utility
Lonza Pharma & Biotech

Spray-dried dispersions (SDDs) are utilized to increase the bioavailability of poorly soluble molecules, however excipient requirements can limit their dose range. A novel platform has been developed to enable SDD dosage forms with high drug loadings, decreasing the size or number of tablets required. Download the whitepaper.

Paid Marketplace
[Case Study] Establishing Parameters for Success

Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Click here to download the Case Study.

Paid Marketplace
[Fact Sheet] Forecasting to Optimize Clinical Trial Supply Management

Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Download the Fact Sheet here.

Accelerate Clinical Operations Across Sponsors, CROs, and Partners With a Best-of-Breed Partner Like Box

The complexity of clinical trials is increasing, and patient recruitment and retention continue to pose challenges. New platforms are providing the life sciences industry with an opportunity  to improve the efficiency of clinical trials and reduce costs while remaining compliant and reducing risk. Download the whitepaper to learn more.

The Art of Recognizing Clinical Supply Risk Factors

In a BioPharma Dive industry survey of 150+ individuals with responsibility for clinical supplies, planning and forecasting were identified as top concerns for trial sponsors and were seen as activities that can yield significant benefits. In response to this need, the Clinical Supply Management (CSM) team at Catalent has developed a factbased methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management. Download now.

Metabolites in Safety Testing (MIST): Analytical Strategy
July 29, 2020 | 1pm EST / 10am PST | Frontage Laboratories

Regulatory agencies have provided recommendations on when and how to identify and characterize drug metabolites to ensure their non-clinical toxicity has been adequately evaluated. The studies conducted to comply with these recommendations are often referred to as metabolites in safety testing or MIST.

This presentation will review the origins of these recommendations and the specific requirements that need to be considered in designing studies to address the regulatory expectations. Register now.

Patients can’t wait: Advancing Rare Disease & Oncology drug development during COVID-19
Recorded on: July 28, 2020 | Parexel

This virtual roundtable will explore the challenges and opportunities facing companies developing oncology and rare disease products during the COVID-19 pandemic. Parexel will be joined by Sara’s Cure, a Clear Cell Sarcoma patient advocacy group and charitable foundation. Register now to learn more.

Bioavailability Toolkit
FierceMarkets Custom Publishing

This industry survey seeks to gain insight on the drug developer’s perspective on bioavailability enhancement technologies and the reasoning behind the use of certain technologies over others in preclinical and early-stage clinical development. Take the survey for a chance to win a $5 Amazon gift card.

Challenges and Practical Solutions for Changing Over to Pre-filled Syringes for Parenteral Drugs
Recorded on July 22, 2020 | Thermo Fisher Scientific

It’s not uncommon for companies who launch commercial drug products in the pre-filled syringe format to do so after initially using other product formats such as vials for the development and clinical trial phases. Switch-overs need careful and strategic consideration because doing so requires investment in the new format but also offers critical patient benefits and improved stakeholder outcomes. During this webinar, you will learn more about benefits and risks of changing primary components during product development and how a design of experiments approach can be used to address issues and risks. Register now.

Zero Deviation Mindset: Achieving Agility in Cell Therapy Supply Chains
Recorded on July 21, 2020 | Pluristem Therapeutics & ThermoFisher Scientific

Cell & gene therapy supply chains are inherently complex, requiring the utmost attention to quality, cold chain logistics, and chain of custody requirements. Join Thermo Fisher Scientific and Pluristem Therapeutics as we discuss lessons learned in developing the just-in-time supply chain for their phase III hip fracture study, and how these lessons are being used in their current efforts to treat severe COVID-19 cases complicated by Acute Respiratory Distress Syndrome (ARDS) in the United States. Register Now.

COVID-19 and Chronic Health Conditions: Monitoring the lifecycle of patient attitudes and behaviors in a global pandemic
Health Union

The world as we knew it prior to COVID-19 no longer exists. Since late 2019, the novel coronavirus has rapidly changed the way people work, play, socialize, relax — essentially, the way they live their lives. In this whitepaper, Health Union summarizes key findings from a series of online surveys among people with chronic health conditions to illustrate how those at higher risk of COVID-19 are reacting and responding to this global health crisis. Download the whitepaper.

BSEPcyte® and MDR3cyte®: Innovative Solutions for Investigating Drug-Induced Liver Injury
July 16, 2020 | 1pm EST / 10am PST | Frontage Laboratories

This presentation will benefit scientists wanting to learn more about DILI and/or those needing guidance on crucial transporter studies for better assessment of DDI potentials that is aligned with regulatory guidance. Register for our Webinar, featuring Kan He, on BSEPcyte® and MDR3cyte®: Innovative Solutions for Investigating Drug-Induced Liver Injury.

How Technology Supports Patient Adherence to Specialty Medicines
Recorded on July 15, 2020 | InterSystems

RxMx’s Chameleon -- built on InterSystems IRIS for Health® -- features a configurable platform and a suite of apps to support the unique needs and challenges facing specialty medicines. Join this webinar to learn how the team has developed a variety of products to support solutions ranging from managing COVID-19 test data to keeping MS patients on track for scheduled infusions.

EMD Serono & Aktana: Bringing Intelligent Engagement to Every Channel
Recorded on Tuesday, July 14, 2020 | Aktana

Join this webinar to hear Joel VanderMeulen, Senior Director, N&I Commercial Strategy and Operations at EMD Serono, and Derek Choy, Co-founder and President at Aktana, discuss:

  • Emerging market trends in the post-COVID world
  • How commercial teams can adapt to the “next normal” 
  • The three key components for successful omnichannel engagement

Register now.

Becoming the early bird: Establishing a dialogue with the FDA around accelerating preclinical research
July 14, 2020 | 10 a.m. EST / 7 a.m. PST | Box
De-risking the Development of Biotherapeutics Using Early Stage In Vitro Expression and Genetic Characterisation Tools
Recorded on: July 8, 2020 | Lonza

There is a high attrition rate during the development of biotherapeutics impacting the high cost of development. Early identification of the preferred expression host for manufacturing, along with lead candidate screening and material supply can help to reduce both attrition rates and cost.  Register for the webinar to learn more.

Paid Marketplace
Webinar, July 8: Oncology in the Era of Precision Medicine
Sponsored by University of Florida College of Pharmacy

University of Florida precision medicine leaders highlight current knowledge and trends to advance the future of health care in this quarterly webinar series. Register today.

Paid Marketplace
Case Study: The Script Lift Impact of Weekly Alert Data On Non Personal Promotion
TI Health

With pharma sales reps sidelined by COVID, communication with professionals is more important now than ever before. TI Health is responding to weekly EMR and Telehealth fueled data feeds, to engage and target 600,000+ professionals who are newly diagnosing and treating patients in your disease states. Download the case study now.

Executive Summary
[Executive Summary] Overcoming Manufacturing Challenges for Accelerated Drug Development

Regardless of the assigned FDA expedited approval designation and approach, the key action items should be: the assurance of a detail-oriented plan and the adaption of a “forward-thinking” approach that will assist in any future challenges and opportunities for growth of each project. Click here to download the Executive Summary.

Paid Marketplace
[Presentation] Flexible Manufacturing Strategies

Get expert insights on strategies to implement flexible manufacturing and different technologies that are easily scalable and reproducible. Click here to download the presentation.

Executive Summary
[Executive Summary] Strategies for Flexible Manufacturing

This whitepaper discusses the benefits of end-to-end solutions and share case studies on how flexible manufacturing strategies can accommodate the changing landscape of pharmaceutical products and help bring a drug to market. Click here to download the executive summary!

What Real-World Data Is Telling Us About Managing Patients in a COVID-19 World
June 30, 2020 | 1pm ET / 10am PT | Optum

In this webinar, Optum will bring together their life sciences consultants, a large payer and pharmaceutical industry experts to share understanding about how patients are managing their medications — and how payers are managing patients — in the ever-changing COVID-19 world. Register now.

Paid Marketplace
How Life Sciences is Combining Drug Therapy with Digital Innovation to Improve Patient Experience and Outcomes

Over the next five years, healthcare data is projected to grow at a rate of 36%. Innovations in drug therapy and technology have opened up new ways of capturing and analyzing information related to patient goals, priorities. Download the infographic now.

Restore Elective Procedures in the new normal with Salesforce
Recorded on June 29, 2020 | Salesforce

We are in unprecedented times causing change and disruption like deferral of elective procedures and restricted access to HCPs. In this webinar, you will learn how MedTech companies are planning to rebound from COVID-19 by digitally re-engaging with physicians, HCPs, and health systems as elective procedure volume rebounds. Register now.

State of Data Analytics and Machine Learning in the Life Sciences Industry: 2020 Benchmarking Survey
Recorded on June 25, 2020 | BHE

This webinar will present the results from BHE's industry survey with FiercePharma on how 100 of your peers are leveraging data analytics to respond to today’s challenges and generate timely, high value insights. The webinar will discuss how data analytics are being conducted across functional areas, how analytics approaches vary according to company size and type, which real-world data sources are most commonly leveraged, and more. Register now!

Scalable protein expression with Pichia pastoris - optimising expression for the highest protein yield
June 25, 2020 | 10am ET / 7am PT | Lonza

In this webinar we will examine a number of the benefits of Lonza’s , XS® Pichia 2.0 including : speed, simple fermentation regimes, robust and scalable processes that can be tuned according to the specific objectives of a program, helping to advance new drug candidates through the development pipeline. We will examine the benefits of XS® Pichia 2.0 by referencing a number of case studies with different molecule formats. Register now.

Cannabinoid Formulation - from Farm to Pharma
Recorded on June 24, 2020 | Lubrizol Life Science

A handful of cannabinoid-based pharmaceutical products are on the market today, and an ever-growing number are in the global development pipeline. Cannabinoids are being explored as a treatment for several indications. However, formulating effective pharmaceutical products with CBD and other cannabinoids introduces scientific, regulatory, and even legal challenges. This webinar will explore key considerations in developing cannabinoid-based pharmaceutical products, including an overview of global pharmaceutical cannabinoid usage today, common challenges formulating with CBD and other cannabinoids, and more. Register now!

Virtual Series: Clinical Trials
June 22-24, 2020 | Free Virtual Event | FierceBiotech

FierceBiotech’s upcoming series will cover technology’s role in clinical trials. Panel discussions include: the use of sensors, wearables and other remote monitoring devices for tracking patient statistics, real-world data and patient-centric technology, and the role manufacturing plays in clinical trials. Register now.

Fail Faster: How Biopharma Companies can Capitalize on Early Drug Development Failures
Recorded on June 19, 2020 | Research Solutions

This Fierce webinar will bring together executives with expertise in biopharma discovery, R&D and clinical trial design to discuss the benefits and challenges of the fail-fast strategy. It will include representatives of companies that have implemented such a strategy successfully and can provide advice on what did and did not work. Click here to register!

Human Gut Microbiome-Based Contract Research Applications in Toxicology and Microbiome-Based Drug Discovery
June 18, 2020 | 12:00pm ET / 9:00am PT | Frontage Labs

Register for our Webinar, featuring David Kwok, on Human Gut Microbiome-Based Contract Research Applications in Toxicology and Microbiome-Based Drug Discovery. Save your spot & register today!

Rapid and Data-Rich Chromatographic Method Development
Recorded on: June 17, 2020 | Cambrex

Rapid and systematic column and mobile phase screening has become an essential component of method development workflows at Cambrex Durham for NCE APIs and drug products. Utilizing the latest technologies in UPLC, a systematic approach to screening in method development can quickly provide more robust methods earlier in the clinical development lifecycle. Register now.

Based on Exclusive Survey: Bioavailability Enhancement – Industry Insights, Key Challenges & Advanced Development Solutions
Recorded on June 16, 2020 | Catalent

Join this webcast as experts present the exclusive survey findings and introduce innovative scalable drug delivery technologies proven to address the industry’s growing need for improving solubility and enhancing bioavailability. Register now.

Under Siege: Challenges and Mitigation Strategies for Clinical Trial Conduct During the COVID-19 Pandemic with Respect to Data Integrity
June 15, 2020 | 11am ET / 8am PT | Parexel

During the current COVID-19 pandemic, regulatory and compliance risk is an acute concern by health authorities, pharmaceutical manufacturers, medical practitioners and patients. This webinar will discuss the challenges and potential mitigation strategies, in accordance with appropriate application of regulations and COVID-19 guidance documents, to ensure GCP compliance with respect to managing lost to follow-up and missing data. Register now.

[Case Study] Revitalizing an Established OTC Brand to Fight Erosion and Increase Market Share

In a series of innovation sessions, Catalent RP Scherer softgel capsules were quickly identified as the ideal solution to drive incremental growth. With a highly-successful launch and halo growth for the entire brand, the new line extension increased the brand’s overall market share. Learn more in this whitepaper.

Transforming medicine with expertise, flexibility and scale
Recorded on June 12, 2020 | Thermo Fisher Scientific

Join us for a webcast that will announce our progress on the 2020 investments to our Pharma Services business and provide focused insight on Thermo Fisher Scientific's expanding gene therapy capabilities. We will also cover an update on our strategy to ensure the delivery of drugs to customers and patients in lieu of the COVID-19 outbreak, as well as our evolving direct response to the virus through several ongoing projects. Register Now.

Strategically Accelerate COVID-19 Diagnostics from Development to Market
June 11, 2020 | 1pm EST / 10am PST | Precision for Medicine

This webinar will explore real-world examples that will help you anticipate pitfalls, mitigate risk and accelerate development. Use the valuable insights we’ve gained from participation in multiple COVID-19 research studies to understand the contingencies for success and, just as critical, to anticipate pitfalls that can be avoided. Click here to save your spot!

Transforming Clinical Development and Discovery with Multi-omic Data in the Era of Precision Medicine
June 9, 2020 11 a.m. EST / 8 a.m. PST | Acorn AI by Medidata, a Dassault Systèmes company

Join industry experts as they propose best practices for incorporating translational omic data in clinical development in order to yield novel insights and improve patient / study outcomes. Register now.

Innovation in OTC Products: A survey report on why it matters and how to achieve it

To better understand why innovation is important to the OTC industry and how it is achieved, Catalent and FiercePharma conducted a survey which generated responses from 233 people from the OTC industry. Download this infographic to learn more about survey results and expert insight on trends uncovered by the survey.

Maximizing the Benefits of a Unified Clinical Data Capture and Management Platform
Recorded on: June 3, 2020 | Medidata

Register for the webinar to see how leveraging multiple solutions on a unified platform streamlines processes, drives operational efficiency, eliminates reconciliation, and provides faster data insights.

Mastering the Virtual Clinical Trial
June 3, 2020 | 11:00am ET / 8:00am PT | CMIC Group

This Fierce webinar will bring together executives with expertise in R&D and technology implementation to explain the potential benefits of virtual clinical trials, as well as the ins and outs of designing and running them. It will include representatives from companies that have completed virtual clinical trials successfully and can provide advice on what did and did not work. Click here to save your spot today!

Driving Quantitative Image Analysis for Early Phase Clinical Trials with Medidata and Medpace
June 2, 2020 | 10:00 am ET / 7:00 am PT | Medpace & Medidata

According to experts, quantitative image analysis can provide surrogate biomarkers in early phase clinical trials. In this webinar, experts discuss a seamless solution that facilitates data management and quantitative analysis of patient imaging data. Click here to register.

The Adherence Marketing Manifesto
HealthPrize Technologies

Download The Adherence Marketing Manifesto to find out how to harness consumer marketing and behavior change tactics to help patients start and stay on their medications.

Rapid BYOD Build Timelines
Clinical Ink

With COVID-19, the value of virtual trials with direct data capture (DDC) is obvious. Bring-your-own-device (BYOD) electronic patient-reported outcome (ePRO) solutions increase adherence while precluding the transfer of devices among patients. Download now!

Keep Your GI Trials Moving During COVID-19
Clinical Ink

Our white paper describes the complexity of GI trials and shows how a therapeutic specific data capture solution overcomes their significant, but typical, challenges. Clinical Ink’s intimate knowledge of and experience with GI trials enables a better deployment experience and improved trial conduct. Download now!

How the fast-changing R&D pipeline is amplifying the importance of adaptable CROs
CMIC Group

Major advances in our understanding of the causes of once-untreatable diseases have reshaped the global drug development pipeline over the past decade, paving the way for better health outcomes for many millions of people. To realize these emerging opportunities, drug developers need access to clinical trial capabilities tailored to the modalities and indications that now dominate their pipelines. To learn more, click here to download the whitepaper.